These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 32428831)

  • 41. [Burn wound treatment through enzymatic debridement: First experience in Switzerland].
    Osinga R; Steiger P; Giovanoli P; Plock JA; Mannil L
    Handchir Mikrochir Plast Chir; 2019 Apr; 51(2):80-85. PubMed ID: 29698995
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Chemical debridement of burns: mercaptans.
    Levenson SM; Gruber DK; Gruber C; Lent R; Seifter E
    J Trauma; 1981 Aug; 21(8):632-44. PubMed ID: 7265335
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Bioengineering methods employed in the study of wound healing of sulphur mustard burns.
    Graham JS; Schomacker KT; Glatter RD; Briscoe CM; Braue EH; Squibb KS
    Skin Res Technol; 2002 Feb; 8(1):57-69. PubMed ID: 12005121
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Efficacy of laser debridement with autologous split-thickness skin grafting in promoting improved healing of deep cutaneous sulfur mustard burns.
    Graham JS; Schomacker KT; Glatter RD; Briscoe CM; Braue EH; Squibb KS
    Burns; 2002 Dec; 28(8):719-30. PubMed ID: 12464469
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Application of hydrosurgery for burn wound debridement: An 8-year cohort analysis.
    Legemate CM; Goei H; Gostelie OFE; Nijhuis THJ; van Baar ME; van der Vlies CH;
    Burns; 2019 Feb; 45(1):88-96. PubMed ID: 30322740
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Assessment of cosmetic and functional results of conservative versus surgical management of facial burns.
    Fraulin FO; Illmayer SJ; Tredget EE
    J Burn Care Rehabil; 1996; 17(1):19-29. PubMed ID: 8808355
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Enzymatic débridement as a treatment option for deep dermal burns of the hand].
    Billner M; Hofmann N; Jaehn T; Püski T; Reichert B
    Unfallchirurg; 2019 Apr; 122(4):323-327. PubMed ID: 30498896
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Minimally invasive burn care: a review of seven clinical studies of rapid and selective debridement using a bromelain-based debriding enzyme (Nexobrid®).
    Rosenberg L; Shoham Y; Krieger Y; Rubin G; Sander F; Koller J; David K; Egosi D; Ahuja R; Singer AJ
    Ann Burns Fire Disasters; 2015 Dec; 28(4):264-274. PubMed ID: 27777547
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Early burn excision and grafting.
    Heimbach DM
    Surg Clin North Am; 1987 Feb; 67(1):93-107. PubMed ID: 3544269
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Releasing Burn-Induced Compartment Syndrome by Enzymatic Escharotomy-Debridement: A Case Study.
    Mataro I; Lanza A; Di Franco S; Di Franco L; Sangiuolo M; Notaro M; d'Alessio R; Villani R
    J Burn Care Res; 2020 Sep; 41(5):1097-1103. PubMed ID: 32232328
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Transfusion-free pediatric burn surgery: techniques and strategies.
    Losee JE; Fox I; Hua LB; Cladis FP; Serletti JM
    Ann Plast Surg; 2005 Feb; 54(2):165-71. PubMed ID: 15655467
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Escharotomy using an enzymatic debridement agent for treating experimental burn-induced compartment syndrome in an animal model.
    Krieger Y; Rosenberg L; Lapid O; Glesinger R; Bogdanov-Berezovsky A; Silberstein E; Sagi A; Judkins K
    J Trauma; 2005 Jun; 58(6):1259-64. PubMed ID: 15995479
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Emergent burn care.
    Harvey JS; Watkins GM; Sherman RT
    South Med J; 1984 Feb; 77(2):204-14. PubMed ID: 6367073
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Tangential excision of eschar for deep burns of the hand: analysis of 156 patients collected over 10 years.
    Wang XW; Sun YH; Zhang GZ; Zhang ZM; Davies JW
    Burns Incl Therm Inj; 1984 Dec; 11(2):92-8. PubMed ID: 6395939
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Coagulation Abnormalities Following NexoBrid Use: A Case Report.
    Martín N; Guilabert P; Abarca L; Usua GM; Serracanta J; Colomina MJ
    J Burn Care Res; 2018 Oct; 39(6):1067-1070. PubMed ID: 29931322
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Burn Debridement: Are We Optimizing Outcomes?
    Bolton L
    Wounds; 2019 Dec; 31(12):298-300. PubMed ID: 31833838
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Management of 2nd-degree facial burns using the Versajet(®) hydrosurgery system and xenograft: a prospective evaluation of 20 cases.
    Duteille F; Perrot P
    Burns; 2012 Aug; 38(5):724-9. PubMed ID: 22360953
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Enzymatic Debridement in Severe Burn COVID-19 Patients: A Case Series.
    Coletta F; Sala C; De Marco GP; Mataro I; Petroccione C; Bonagura P; Pirolli R; Foreste G; Tomasello A; Villani R
    Plast Reconstr Surg Glob Open; 2023 Jan; 11(1):e4808. PubMed ID: 36714389
    [TBL] [Abstract][Full Text] [Related]  

  • 59. An Overview of the Use of Bromelain-Based Enzymatic Debridement (Nexobrid®) in Deep Partial and Full Thickness Burns: Appraising the Evidence.
    Loo YL; Goh BKL; Jeffery S
    J Burn Care Res; 2018 Oct; 39(6):932-938. PubMed ID: 29579268
    [TBL] [Abstract][Full Text] [Related]  

  • 60. E-cigarette burn injuries: Comprehensive review and management guidelines proposal.
    Jones CD; Ho W; Gunn E; Widdowson D; Bahia H
    Burns; 2019 Jun; 45(4):763-771. PubMed ID: 30442380
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.